youtube linkedin twitter facebook

Company news

A little time Down Under…

1st October 2016


From 22nd to 23rd September, we attended The Sydney Cancer Conference, a meeting for cancer researchers and all those in related research areas. 

The Sydney Opera House

For the first time, this conference was co-hosted by six major New South Wales Universities: The University of Sydney, the University of New South Wales, Macquarie University, University of Wollongong, University of Newcastle and the University of Western Sydney.

The restored Eveleigh Railway Yards

The conference, held at The Australian Technology Park in the beautifully restored Eveleigh Railway Yards, gave Oxford Optronix the opportunity to meet with many familiar faces, to introduce new developments with our GelCount and OxyLite instruments, and to launch the HypoxyLab hypoxia workstation in Australia.

Members of the Department of Radiation Oncology, Chris O'Brien Lifehouse, Sydney; prospective customers of our GelCount system

The meeting was a great success, with more than 400 attendees representing a dynamic and intensive area of scientific reproach in Australia.

Oxford Optronix was represented at the conference by our Sales Manager, Petra Mayr, and by our Business Development Principle, John Coyle.

Petra followed the meeting with a round of highly informative support visits to some of our key customers in Australia, including at Monash University in Melbourne, at The University of Melbourne and at Charles Sturt University in Wagga Wagga.

Australia has been a particularly strong market for our OxyLite™ and OxyFlo™ brands of tissue vitality monitors, with various teams at the forefront of research areas such as renal oxygenation and kidney failure, haemorrhagic shock and resuscitation.

Find out more:

  • OxyLite™ – Tissue dissolved oxygen monitors
  • OxyFlo™ – Tissue blood perfusion monitors
  • GelCount™ – The leading colony and spheroid counter for cancer biologists
  • HypoxyLab™ – Authentic hypoxia in a bench-top workstation



News Archive




11th April 2019
WellBeing™ clinical trials commence

5th February 2019
Article highlight

2nd January 2019
Happy New Year!